.view-toggle-wrapper { display: none; } #content-overview { display: block !important; } #content-technical { display: block !important; margin-top: 50px; border-top: 2px solid #ccc; padding-top: 30px; }

Use the toggle to switch between the simple Overview and the Technical Data content.

Rhodiola Rosea: Uses, Benefits, and What to Know

Overview

Plain-English information for everyday use

1. What Is Rhodiola Rosea?

Key Takeaway

Rhodiola rosea is a cold-climate herb whose root is used as an "adaptogen" — a traditional term for plants people take to help the body cope with occasional stress and to support stamina and mental sharpness. It's sold as a standardized root extract, not as a food.

Rhodiola rosea — also called roseroot, golden root, or Arctic root — is a hardy plant that grows on rocky mountain slopes across the Arctic and high-altitude regions of Europe, Asia, and North America. The part used is the underground root and rhizome, which has a faint rose-like scent when freshly cut. EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Rhodiola rosea L., rhizoma et radix. 2024. Open Source ↗

It belongs to a group of plants often called adaptogens — a traditional category for herbs taken to help the body steady itself during times of stress or hard effort. Rhodiola is one of the better-known adaptogens, alongside ashwagandha and eleuthero. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

The two best-known active compounds in the root are salidroside and the rosavins. Good-quality extracts are usually standardized to a set ratio of these — commonly around 3% rosavins and 1% salidroside. The rosavins are distinctive to Rhodiola rosea specifically, which is why they're used to tell true roseroot apart from look-alike species. National Center for Biotechnology Information. PubChem Compound Summary: Salidroside, CID 159278. Open Source ↗ National Center for Biotechnology Information. PubChem Compound Summary: Rosavin, CID 9823887. Open Source ↗

Key Highlights

A cold-climate herb — the root and rhizome are the part used
One of the traditional "adaptogens" taken to help the body cope with occasional stress
Active compounds: salidroside and the rosavins (rosavins are specific to true Rhodiola rosea)
Sold as a standardized extract, often ~3% rosavins / 1% salidroside
Used in folk traditions of Siberia, Scandinavia, and Russia
Not a food and not a vitamin — there is no dietary requirement for it

2. Why People Reach for Rhodiola

Key Takeaway

People most often try rhodiola during stretches of stress, tiredness, or mental fog, or to support physical stamina. Those everyday feelings are very common and have many different causes, so rhodiola is best thought of as general support — not an answer to any specific problem.

Rhodiola is usually reached for during busy, demanding, or tiring stretches of life. The reasons people give below are ordinary experiences that almost everyone has from time to time — and on their own they don't point to any one cause, so it's worth talking with your healthcare provider if they're persistent or new: National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

Feeling worn down or low on energy during a demanding period
Everyday tiredness or fatigue that comes with long hours or poor sleep
Mental fog or trouble keeping focus when you're stretched thin
Wanting general support for physical stamina and effort
Looking for a traditional herb to help cope with occasional stress
An interest in adaptogens as part of a broader wellness routine

None of these feelings is specific to anything rhodiola does — they are not specific and can have many different causes, from sleep and workload to nutrition or an underlying health matter. Rhodiola is not a substitute for rest, and it is not a fix for any specific health problem. If tiredness, low mood, or trouble concentrating is ongoing, please speak with your provider before assuming a supplement is the answer.

3. Who Should Be Careful or Talk to a Provider

Key Takeaway

Rhodiola interacts with several common medicines and isn't right for everyone. If you take prescription medicines for mood, blood thinning, blood sugar, or blood pressure, are pregnant or breastfeeding, are under 18, or have surgery coming up, check with your provider before starting rhodiola.

Rhodiola is generally well tolerated by healthy adults for short periods, but it is more than an inert herb — it appears to act on body systems that some prescription medicines also act on. Talk with your healthcare provider first if any of the following apply to you:

You take a prescription medicine for mood (such as an antidepressant or an MAOI). Rhodiola appears to act on some of the same brain chemicals (like serotonin) as these medicines, and case reports describe overstimulation when the two were combined without supervision. Maniscalco I, et al. Neuropsychiatr. 2015. Open Source ↗
You take a blood thinner such as warfarin. In lab and animal studies rhodiola can change how some medicines are broken down, which may affect how the blood thinner works. Hellum BH, et al. Planta Med. 2010. Open Source ↗
You take medicine for blood sugar or blood pressure. Rhodiola may add to those effects, so your readings are worth watching with your provider.
You have a history of significant mood swings of the kind managed by a mental-health specialist. Rhodiola can be overstimulating, and a case report describes an episode of unusually elevated, "high" mood linked to its use — so check with that specialist first. Whig R, Leo RJ. Prim Care Companion CNS Disord. 2022. Open Source ↗
You have an autoimmune condition or take medicine that quiets the immune system — discuss rhodiola with your provider before starting.
You have reduced liver or kidney function — how your body handles rhodiola may differ, so get provider guidance.
You have surgery coming up — because of the possible effects on bleeding, blood sugar, and blood pressure, many providers advise stopping herbal supplements about two weeks beforehand.

If You're Pregnant or Breastfeeding

P-3 — Insufficient evidence Breast-milk transfer: T-U (unknown)

Pregnancy: Rhodiola is not recommended during pregnancy. There simply isn't reliable human safety information for it in pregnancy, and the European herbal-medicines regulator advises against its use while pregnant for that reason. Because the data are absent rather than reassuring, the safe choice is to avoid it — if you're pregnant or trying to conceive, talk to your OB or midwife before taking any herbal supplement. EMA Committee on Herbal Medicinal Products (HMPC). EU herbal monograph: Rhodiolae roseae rhizoma et radix. 2024. Open Source ↗

Breastfeeding: Rhodiola is not recommended while breastfeeding. No studies have measured whether its compounds pass into breast milk or how they might affect a nursing baby, so the exposure is genuinely unknown. With no safety data either way, avoiding it is the cautious choice — bring any questions to your IBCLC or pediatrician before starting a supplement. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

Discontinue and Seek Medical Attention If:

You're taking rhodiola alongside a mood medicine and feel restless, shaky, sweaty, feverish, confused, or notice a racing or irregular heartbeat — stop and seek medical advice promptly. Maniscalco I, et al. Neuropsychiatr. 2015. Open Source ↗
You feel unusually wired, sped-up, or "high," sleep far less than normal, or your thoughts feel like they're racing — stop and contact your provider.
You have a rash with itching, swelling, or difficulty breathing after a supplement — this could be a reaction to the product or an ingredient.

Under 18: rhodiola is not recommended for children or teenagers, as it hasn't been studied for safety in this age group.

4. How to Get the Best Results

Key Takeaway

Take rhodiola in the morning (it can be activating and disturb sleep if taken late), choose a standardized extract, start with a low amount, and give it a fair trial. Keep your provider in the loop if you take other medicines.

Simple Ways to Use Rhodiola Sensibly

Take it earlier in the day. Rhodiola can feel mildly activating for some people, so morning or early afternoon is usually better than evening to avoid disturbed sleep. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗
Pick a standardized extract. Look for one standardized to rosavins and salidroside (often listed as ~3% rosavins / 1% salidroside) — this is how the product is kept consistent batch to batch. EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Rhodiola rosea L., rhizoma et radix. 2024. Open Source ↗
Start low. A smaller amount to begin lets you see how you respond before adjusting, and helps you notice any over-stimulation.
Give it a fair trial. Some traditional uses are for short, defined stretches rather than indefinitely; many people use it for a number of weeks and then take a break.
Keep your provider in the loop. If you take prescription medicines — especially for mood, blood thinning, blood sugar, or blood pressure — check before starting and let them know you're using it.
Buy from a tested source. Rhodiola is a commonly adulterated herb, so third-party testing matters (see Section 10).

Rhodiola is general, traditional support — not a fix for a specific condition. If you don't notice anything over a reasonable trial, there's no need to keep taking it.

5. Side Effects

Key Takeaway

Most healthy adults tolerate rhodiola well for short periods. The most common complaints are feeling over-stimulated or jittery, trouble sleeping if taken late, dizziness, dry mouth, or mild stomach upset. Effects on mood and over-stimulation are the ones to watch.

In the short-term studies that have been done, rhodiola has generally been well tolerated and side effects have usually been mild. The ones people report most often are: National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

Feeling over-stimulated, restless, or jittery — more likely at higher amounts
Trouble falling asleep, especially if taken in the afternoon or evening
Lightheadedness or dizziness
Dry mouth
Mild stomach upset

Less commonly, some people feel unusually wired or "sped up." Long-term safety hasn't been well studied, which is part of why many traditional uses are for shorter stretches. If you feel over-stimulated, an unusually elevated "high" mood, or your sleep is disrupted, ease off and check with your provider. Whig R, Leo RJ. Prim Care Companion CNS Disord. 2022. Open Source ↗

6. What Research Suggests

Key Takeaway

Rhodiola has been studied mostly for occasional stress, fatigue, mental performance, and physical stamina — but the trials are small, short, and mixed, and some found no benefit at all. The honest summary is that the evidence is limited and far from settled.

Rhodiola has been looked at in a number of small human trials, mostly short studies in students, shift workers, and people feeling run down. The areas studied most are occasional stress and fatigue, mental performance when tired, and physical stamina. Olsson EM, et al. Planta Med. 2009. Open Source ↗ Spasov AA, et al. Phytomedicine. 2000. Open Source ↗

The catch is that these trials are small, short, and inconsistent. Some reported people felt less worn down or sharper; others — including a careful trial in nursing students — found no benefit over placebo. Punja S, et al. PLoS One. 2014. Open Source ↗ Independent reviews that pooled the studies came to a cautious conclusion: the research is too limited and too varied in quality to draw firm conclusions. Hung SK, Perry R, Ernst E. Phytomedicine. 2011. Open Source ↗ Ishaque S, et al. BMC Complement Altern Med. 2012. Open Source ↗

So while rhodiola has a long traditional reputation and some encouraging small studies, the science behind it is still early and mixed. It's reasonable to think of it as general, traditional support to try — not as something proven to do a specific job. The U.S. regulator has, in fact, warned companies that made unsupported health claims about rhodiola products. U.S. Food and Drug Administration. Structure/Function Claims. Open Source ↗

7. Where Rhodiola Comes From

Key Takeaway

Rhodiola isn't a food — it's a wild mountain root, traditionally harvested in Siberia and Scandinavia, and now sold as a standardized extract. Because wild stands have been over-harvested, it's now an internationally protected plant, so sustainable, cultivated sourcing matters.

Unlike a vitamin or a food-based nutrient, rhodiola doesn't come from the diet — you won't find it in groceries. It's the root of a wild alpine plant, and a major commercial source has long been the Altai mountains of Asia. The roots are dried and made into a concentrated, standardized extract for capsules and tablets. EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Rhodiola rosea L., rhizoma et radix. 2024. Open Source ↗

Wild rhodiola grows slowly and has been heavily collected, so populations in several regions have declined. As of 2023, Rhodiola was added to the international CITES list of protected species, which regulates trade in the wild plant. In practice this means responsibly grown, cultivated rhodiola — rather than wild-stripped root — is the more sustainable choice, and a sign of a thoughtful supplier. Panossian A, Wikman G, Sarris J. Phytomedicine. 2010. Open Source ↗

8. Body Systems It's Linked To

Key Takeaway

Rhodiola is most associated with the body's stress-response system, with mental performance, and with physical energy and stamina. These are the areas its traditional use and early research focus on.

Most of the interest in rhodiola centers on a few connected systems:

The stress-response system. Adaptogens are traditionally taken to help the body steady itself during stress, and rhodiola's early research has looked at how it interacts with the body's stress-hormone (cortisol) signaling. Olsson EM, et al. Planta Med. 2009. Open Source ↗
Mental performance. Several small studies have looked at focus and mental work during tiring conditions such as night shifts and exams. Shevtsov VA, et al. Phytomedicine. 2003. Open Source ↗ Darbinyan V, et al. Phytomedicine. 2000. Open Source ↗
Physical energy and stamina. Some studies have examined stamina and effort, with a few suggesting a short-term signal and longer ones showing little. De Bock K, et al. Int J Sport Nutr Exerc Metab. 2004. Open Source ↗

These connections describe where the research and tradition point — they are general structure-and-function ideas, they are not medical claims.

9. Frequently Asked Questions

What is rhodiola rosea used for?

Rhodiola is a traditional adaptogen herb that people take as general support during stretches of stress, tiredness, or hard mental and physical effort. It has a long folk history in Siberia, Scandinavia, and Russia. It's important to know that the modern research is small and mixed, so rhodiola is best seen as general, traditional support rather than something proven to do a specific job. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

How much rhodiola do people take, and when?

Studies have most often used standardized extracts in the range of about 200 to 600 mg per day, standardized to roughly 3% rosavins and 1% salidroside. Because rhodiola can be mildly activating, it's usually taken in the morning or early afternoon rather than the evening. Starting low and seeing how you respond is sensible, and many traditional uses are for defined stretches rather than indefinitely. Spasov AA, et al. Phytomedicine. 2000. Open Source ↗

Does rhodiola interact with any medicines?

Yes — this is the main thing to know. Rhodiola appears to act on some of the same brain chemicals as prescription medicines for mood, so combining them without medical advice has been linked to over-stimulation in case reports. It can also affect how the body handles certain medicines, including blood thinners such as warfarin, and it may add to medicines for blood sugar or blood pressure. If you take any prescription medicine, check with your provider before using rhodiola. Maniscalco I, et al. Neuropsychiatr. 2015. Open Source ↗ Hellum BH, et al. Planta Med. 2010. Open Source ↗

Can I take rhodiola if I'm pregnant or breastfeeding?

Rhodiola is not recommended during pregnancy or while breastfeeding. There is no reliable human safety information for it in either situation, and the European herbal-medicines regulator advises against use in pregnancy for that reason. Because the data are simply absent rather than reassuring, the cautious choice is to avoid it and to ask your OB, midwife, or pediatrician about anything you're considering. EMA Committee on Herbal Medicinal Products (HMPC). EU herbal monograph: Rhodiolae roseae rhizoma et radix. 2024. Open Source ↗

Will rhodiola keep me awake?

It can, for some people. Rhodiola is mildly activating for many users, so taking it late in the day can make it harder to fall asleep. Taking it in the morning or early afternoon usually avoids this. If you notice you feel wired or your sleep is disrupted, lowering the amount or stopping is reasonable. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

How do I choose a good rhodiola product?

Rhodiola is one of the more frequently adulterated herbs — testing has found products substituted with cheaper look-alike species or spiked with synthetic salidroside. Look for a product that names Rhodiola rosea specifically, is standardized to rosavins and salidroside, and has been third-party tested for identity and for contaminants such as heavy metals. Cultivated (rather than wild-harvested) sourcing is also a good sign. Porwollik S, Jafari M. PLoS One. 2026. Open Source ↗

Is rhodiola allowed for athletes?

Rhodiola itself is not on the prohibited list for sport, but athletes should be careful: dietary supplements are sometimes contaminated with banned substances not shown on the label, and athletes are held responsible for whatever is in their system. If you compete under anti-doping rules, choose products that carry independent sport-testing certification and confirm the current status of any ingredient with your governing body. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

10. Choosing a Quality Supplement

Key Takeaway

Rhodiola is one of the most adulterated herbs on the market, so quality really matters. Look for a product that names Rhodiola rosea, is standardized to rosavins and salidroside, is third-party tested for identity and heavy metals, and uses sustainable, cultivated sourcing.

Independent testing has repeatedly found problems with rhodiola products. Surveys of the market have reported items substituted with cheaper related species (such as Rhodiola crenulata), products spiked with lab-made salidroside to hit a label number, and roughly only a portion of products being authentic true roseroot. A 2026 analysis of products bought in the United States also flagged wide variation in marker content and traces of heavy metals in some. Porwollik S, Jafari M. PLoS One. 2026. Open Source ↗

What to Look For

The right species: the label should say Rhodiola rosea — not just "rhodiola" or another species
Standardization: a stated rosavins and salidroside content (commonly ~3% rosavins / 1% salidroside)
Identity testing: confirmation it's genuine roseroot, ideally by a method that detects substitution
Contaminant testing: third-party screening for heavy metals and pesticides
Sustainable sourcing: cultivated rather than wild-stripped root, given rhodiola's protected status
Sport certification (for athletes): independent banned-substance testing

11. Your Genes & Rhodiola

Key Takeaway

You don't need a genetic test to use rhodiola. But your own liver-enzyme makeup can influence how strongly rhodiola affects certain medicines — another reason to coordinate with your provider if you take prescriptions.

Everyone's liver processes substances a little differently, partly because of inherited differences in drug-handling enzymes. One of these enzymes, called CYP2C9, helps break down some medicines (including the blood thinner warfarin). Lab and human studies suggest rhodiola can slow this enzyme, and the size of that effect may differ from person to person depending on their enzyme makeup. Hellum BH, et al. Planta Med. 2010. Open Source ↗

The practical takeaway isn't to get tested — it's that if you take a medicine that depends on this enzyme, rhodiola could change how much of that medicine is in your system, so your provider's input matters. For most healthy people not on those medicines, this is a background detail rather than something to act on.

12. Traditional Roots

Key Takeaway

Rhodiola has a long folk history across the cold north — Siberia, Scandinavia, and Russia — where people traditionally used the root to cope with cold, hard work, and long winters, and to support stamina.

Rhodiola's reputation is rooted in the traditions of cold, mountainous regions. In Siberia and across the Russian north, the root was a folk remedy taken to keep going through harsh conditions, fatigue, and long winters. Scandinavian traditions valued roseroot too — it appears in old Nordic folk use, and there are tales of Vikings using it for endurance and strength. Panossian A, Wikman G, Sarris J. Phytomedicine. 2010. Open Source ↗

This is the traditional backdrop to why rhodiola is grouped with the "adaptogens" — herbs taken to help the body weather stress and effort. Tradition is part of why people are interested, but it isn't the same as modern proof, which (as Section 6 explains) remains limited.

13. Story Behind the Science

Key Takeaway

Much of rhodiola's modern reputation comes from mid-20th-century Soviet research, where it was studied for stamina and resilience. The idea of an "adaptogen" was coined in that era, and Western interest grew once those studies became more widely known.

Rhodiola moved from folk remedy toward laboratory study in the Soviet Union. Soviet scientists were interested in plants that might help people withstand stress and stay sharp under pressure, and rhodiola became a subject of that work. Out of this research came the concept of an "adaptogen" — a substance proposed to raise the body's general, non-specific resistance to strain — formally described by Soviet scientists in the late 1960s. Panossian A, Wikman G, Sarris J. Phytomedicine. 2010. Open Source ↗

Because much of the early work was published in Russian and some was not widely circulated, rhodiola was slower to reach Western shelves. As the studies became better known and standardized extracts (used in several of the modern trials) were developed, interest spread internationally — though, as Section 6 notes, the modern evidence is still building. Olsson EM, et al. Planta Med. 2009. Open Source ↗

14. Lab Tests

Key Takeaway

There's no blood test for rhodiola itself — it isn't a nutrient you measure. But if you take warfarin, rhodiola could affect your blood-clotting test (INR), so your provider may want to keep an eye on it.

Unlike a vitamin or mineral, rhodiola has no routine blood test — there's no standard "rhodiola level" measured in clinical care, and you don't need one to use it. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

Where lab tests come in is through rhodiola's possible effect on certain medicines. The clearest example is the blood thinner warfarin: because rhodiola may change how warfarin is handled, it could shift the INR — the blood test used to keep warfarin in its safe range. If you take warfarin and start or stop rhodiola, your provider may want to check your INR. Similarly, if you take medicine for blood sugar or blood pressure, the usual monitoring for those still applies. Hellum BH, et al. Planta Med. 2010. Open Source ↗

✓ Last Reviewed: June 2026

Rhodiola Rosea

Technical Data

Clinical reference for healthcare professionals

CLINICAL SUMMARY

Rhodiola Rosea

Adaptogenic dry extract of Rhodiola rosea L. (Crassulaceae) root and rhizome, standardized to rosavins and salidroside (commonly ~3% / ~1%). Proposed to support the body's adaptive stress response via HPA-axis/cortisol modulation and stress-defense signaling (neuropeptide-Y, Hsp72); in-vitro monoamine-oxidase inhibition is described. Most mechanism and pharmacokinetic data are preclinical; human efficacy data are limited and mixed.

Overall Evidence

WEAK / MIXED

Primary Uses Studied

WEAKOccasional stress and fatigue · most-studied area; small RCTs with mixed and inconsistent results
WEAKMental performance under fatigue · small, short-duration RCTs (shift work, exams)
WEAKPhysical / exercise stamina · acute studies suggest a signal; longer-term studies largely null
INSUFFICIENTLow mood · few small trials; not adequately controlled to draw conclusions

Standard Intake Range

Typical: 200–600 mg/d standardized extract (≈3% rosavins / 1% salidroside)
Acute: single 200–600 mg doses studied for short-term mental performance
Timing: morning / early afternoon (activating; can disturb sleep). Not recommended <18; no formal upper-intake level established

Key Safety Flags

🟢 STANDARD Generally well tolerated short-term in healthy non-pregnant adults; not currently listed as prohibited in sport (confirm current annual list)
🟠 CAUTION Serotonergic / MAO activity in vitro — additive pharmacodynamic effect with serotonergic agents reported in case reports (over-stimulation)
🟠 CAUTION In-vitro/human inhibition of CYP2C9, CYP3A4 and P-glycoprotein — may raise exposure of narrow-margin substrates (e.g., warfarin); coordinate
🟠 CAUTION Additive potential with glucose-lowering and blood-pressure agents — monitor
🟠 CAUTION Can be over-stimulating; a case of markedly elevated mood reported — specialist input where a mood condition is specialist-managed
🔴 AVOID Pregnancy and lactation — not recommended (safety not established)
🔴 AVOID Under 18 — not recommended (not studied)

Monitoring Quick-Ref

No rhodiola assay: there is no clinical reference interval for salidroside/rosavin — rhodiola itself is not measured
INR: if co-used with warfarin (CYP2C9 substrate) — check around starting/stopping
Glucose / blood pressure: if co-used with relevant agents

⚠️ Lab Interference

Rhodiola has no direct assay interference of its own — but its inhibition of CYP2C9 can raise the exposure (and the INR) of CYP2C9 substrates such as warfarin, and may raise measured levels of other narrow-margin substrates. Interpret affected drug levels and INR in light of recent rhodiola use; there is no test for rhodiola itself.

Clinical bottom line: An adaptogen with a biologically plausible stress-response mechanism but limited, mixed human evidence and several null trials. The dominant practical considerations are not efficacy but interaction and product-quality risk: serotonergic/MAO additivity with mood medicines, CYP2C9/3A4 and P-gp inhibition (warfarin and other narrow-margin substrates), additive effects with glucose-lowering and antihypertensive agents, frequent product adulteration, and not-recommended status in pregnancy, lactation, and under 18.

1. Chemical Identity & Forms

Key Takeaway

Rhodiola rosea L. (Crassulaceae), root/rhizome. Marker compounds: salidroside (a tyrosol glucoside) and the rosavins (cinnamyl-alcohol glycosides, specific to the species). EMA-characterized preparation: dry extract, DER 1.5–5:1, ethanol 67–70%. Multiple marker-defined extract types exist.

Botanical name	Rhodiola rosea L.
Family	Crassulaceae
Common names	Golden root, arctic root, roseroot
Part used	Dried root and rhizome
Marker compounds	Salidroside (rhodioloside) and the rosavins (rosavin, rosin, rosarin)
Salidroside chemistry	CAS 10338-51-9; C₁₄H₂₀O₇; 300.31 g/mol; PubChem CID 159278
Typical standardization	~3% rosavins / ~1% salidroside
EMA-characterized extract	Dry extract, DER 1.5–5:1, ethanol 67–70%
Species note	100+ species in the genus; data are specific to R. rosea (not R. crenulata)

Botanical identity. Rhodiola rosea L., family Crassulaceae; the herbal substance is the dried root and rhizome. The genus has 100+ species; most clinical and animal data are specific to R. rosea, and cross-species extrapolation (e.g., from R. crenulata) is not automatic. EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Rhodiola rosea L., rhizoma et radix. 2024. Open Source ↗

Marker chemistry. Salidroside (rhodioloside): CAS 10338-51-9; C₁₄H₂₀O₇; 300.31 g/mol; a glucoside of tyrosol; PubChem CID 159278. National Center for Biotechnology Information. PubChem Compound Summary: Salidroside, CID 159278. Open Source ↗ Rosavin: CAS 84954-92-7; C₂₀H₂₈O₁₀; 428.43 g/mol; a cinnamyl-alcohol diglycoside; PubChem CID 9823887. The rosavins are characteristic of R. rosea specifically, whereas salidroside occurs across the genus. National Center for Biotechnology Information. PubChem Compound Summary: Rosavin, CID 9823887. Open Source ↗

Preparation & forms. The EMA-characterized preparation is a dry extract, DER 1.5–5:1, extraction solvent ethanol 67–70% v/v, in solid oral dosage forms. Named standardized research extracts include SHR-5 and WS 1375. Five marker compounds are used to authenticate the species: rosavin, rosin, rosarin, rosiridin, and salidroside. Commercial products are often standardized to ~3% rosavins / ~1% salidroside. EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Rhodiola rosea L., rhizoma et radix. 2024. Open Source ↗

2. Mechanism of Action

Key Takeaway

Proposed actions are largely preclinical: in-vitro monoamine-oxidase (MAO-A/B) inhibition; modulation of HPA-axis/cortisol signaling (one human RCT signal); and induction of stress-defense mediators (neuropeptide-Y, Hsp72). No single mechanism is established as clinically determinative.

Proposed mechanism	Evidence level	Note
Monoamine oxidase (MAO-A/B) inhibition	In vitro only	High concentration (~100 µg/mL); basis of the serotonergic-additivity caution
HPA-axis / cortisol modulation	One human RCT	Reduced cortisol awakening response
Stress-defense mediators (neuropeptide-Y, Hsp72)	Preclinical	Supports a stress-resilience hypothesis

Monoamine oxidase (in vitro). Methanol and water root extracts inhibited MAO-A and MAO-B at high concentration (~100 µg/mL) in a microtiter bioassay. This is an in-vitro finding at high concentration and is not established as clinically meaningful MAO inhibition in vivo — but it is the mechanistic basis for the serotonergic-additivity caution. van Diermen D, et al. J Ethnopharmacol. 2009. Open Source ↗

HPA-axis / cortisol. In a randomized controlled trial in adults with stress-related fatigue, repeated dosing of the SHR-5 extract was associated with a reduced cortisol awakening response; the proposed mechanism is normalization of cortisol signaling via stress-activated protein kinases. This is a single clinical signal within a small literature. Olsson EM, et al. Planta Med. 2009. Open Source ↗

Stress-defense signaling. In neuroglia cell models, salidroside and adaptogen blends increased expression/release of neuropeptide-Y and the 72-kDa heat-shock protein (Hsp72), with neuropeptide-Y identified as a central upstream mediator. Mechanistic and preclinical. Panossian A, Wikman G, Sarris J. Phytomedicine. 2010. Open Source ↗

3. Pharmacokinetics (ADME)

Key Takeaway

Human PK is sparse. For salidroside, peak concentration is reached at roughly 2 hours and it is largely cleared by about 8 hours; oral bioavailability is low and variable. p-Tyrosol is a CNS-penetrant metabolite. Most detailed ADME data are from animal models.

Absorption. After oral dosing, salidroside reaches peak plasma concentration at approximately 2 hours; reported oral bioavailability is low and variable, and direct human food-effect data are limited. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

Distribution & metabolism. Salidroside is hydrolyzed to its aglycone p-tyrosol, which crosses the blood–brain barrier — relevant to both proposed central effects and the basis for caution in lactation. Detailed tissue-distribution and metabolism data derive from animal studies. Panossian A, Wikman G, Sarris J. Phytomedicine. 2010. Open Source ↗

Excretion / clearance. In available human data, salidroside is largely cleared by approximately 8 hours, which underpins the practical guidance to separate rhodiola dosing from interacting medicines and to dose earlier in the day. Hellum BH, et al. Planta Med. 2010. Open Source ↗

4. Organ System Effects

Key Takeaway

Effects of interest concentrate on the CNS/neuroendocrine stress axis, on cognitive performance under fatigue, and on exercise physiology. Much organ-level data is preclinical or from disease-model animal work and should not be read as clinical effect in humans.

System	Area of interest	Notes
Central nervous / neuroendocrine	Stress axis — cortisol and stress-defense mediators	Most consistent line of interest
Cognitive	Sustained attention, mental work under fatigue	Small, short trials; mixed effect sizes
Exercise / muscular	Exercise physiology	Largely preclinical or mixed

Central nervous / neuroendocrine. The most consistent line of interest is the stress axis — cortisol signaling and stress-defense mediators (Section 2) — with preclinical anti-fatigue and behavioral models supporting a stress-resilience hypothesis. Olsson EM, et al. Planta Med. 2009. Open Source ↗

Cognitive performance. Small human trials examined sustained attention and mental work under fatiguing conditions (night duty, examinations), with short-duration designs and mixed effect sizes. Shevtsov VA, et al. Phytomedicine. 2003. Open Source ↗ Darbinyan V, et al. Phytomedicine. 2000. Open Source ↗

Musculoskeletal / exercise. Acute dosing has shown a signal on endurance measures in some studies, while longer-term supplementation has generally not reproduced this — a pattern of acute-but-not-chronic effect. De Bock K, et al. Int J Sport Nutr Exerc Metab. 2004. Open Source ↗

5. Dose Tiers

Key Takeaway

Studied amounts cluster around 200–600 mg/d of standardized extract (≈3% rosavins / 1% salidroside), with single acute doses used for short-term mental-performance studies. Morning dosing is preferred. No formal upper-intake level is established; not for under-18s.

Tier	Amount (standardized extract)	Notes
Entry / general	~100–200 mg/d	Conservative start to assess tolerance and activation
Standard functional	~200–400 mg/d	Range used in much of the stress/fatigue literature (SHR-5 and similar)
Upper studied	up to ~600 mg/d	Single acute 200–600 mg in short-term mental-performance studies
Administration	Morning / early afternoon	Activating; standardize to rosavins + salidroside; not for under-18s; no formal UL

5A. Intake Tiers (standardized extract)

Entry / general tier: ~100–200 mg/d — a conservative starting amount to assess tolerance and activation.
Standard functional tier: ~200–400 mg/d — the range used in much of the stress/fatigue and mental-work literature (SHR-5 and similar extracts).
Upper studied tier: ~up to ~600 mg/d, or single acute doses ~200–600 mg studied for short-term mental performance.

Administration. Take in the morning or early afternoon owing to its activating quality; standardize to rosavins and salidroside; many traditional regimens are time-limited rather than continuous. Spasov AA, et al. Phytomedicine. 2000. Open Source ↗ EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Rhodiola rosea L., rhizoma et radix. 2024. Open Source ↗

Boundaries. No formal upper-intake level has been set. Use in those under 18 is not recommended (not studied), and use in pregnancy/lactation is not recommended (Section 10).

6. Clinical Evidence

Key Takeaway

The human evidence base is small RCTs and a couple of systematic reviews, concentrated in stress/fatigue and mental work. Findings are inconsistent, several trials are null, and reviewers judge the overall quality limited. No endpoint reaches a strong evidence grade.

Stress & fatigue (most-studied). Small RCTs in students, physicians on night duty, and adults with stress-related fatigue have reported reductions in self-rated fatigue and improved mental-work measures — but designs are short and effect sizes vary. Olsson EM, et al. Planta Med. 2009. Open Source ↗ Spasov AA, et al. Phytomedicine. 2000. Open Source ↗ Darbinyan V, et al. Phytomedicine. 2000. Open Source ↗ A well-conducted RCT in nursing students found no benefit over placebo, illustrating the inconsistency. Punja S, et al. PLoS One. 2014. Open Source ↗

Burnout / work-related exhaustion. An open-label, manufacturer-affiliated exploratory study in adults experiencing burnout reported within-group changes; the open-label design and sponsorship limit inference. Kasper S, Dienel A. Neuropsychiatr Dis Treat. 2017. Open Source ↗

Low mood. A small randomized trial compared a rhodiola extract with a prescription comparator and placebo in adults with low mood; it was small and underpowered, and the evidence here is best described as insufficient. Mao JJ, et al. Phytomedicine. 2015. Open Source ↗

Systematic reviews. Independent reviews pooling the RCTs concluded that methodological quality is limited and results too heterogeneous to support firm conclusions — an evidence base that is suggestive at best, not confirmatory. Hung SK, Perry R, Ernst E. Phytomedicine. 2011. Open Source ↗ Ishaque S, et al. BMC Complement Altern Med. 2012. Open Source ↗

7. Pharmacogenomics & Genetics

Key Takeaway

No actionable rhodiola pharmacogenomic test exists. The relevant pharmacogenetic axis is the patient's, not rhodiola's: CYP2C9 metabolizer status modulates the magnitude of rhodiola's CYP2C9-mediated interactions (e.g., with warfarin).

Rhodiola has no genotype-directed dosing. The pharmacogenetic relevance runs through interacting drugs: rhodiola inhibits CYP2C9, and the practical impact of that inhibition is shaped by the patient's CYP2C9 metabolizer phenotype — the effect has been described as more pronounced in extensive metabolizers. Where a patient takes a CYP2C9 substrate with a narrow margin (warfarin, phenytoin), this interaction matters more than any rhodiola genotype. Routine pharmacogenomic testing is not indicated for rhodiola use itself. Hellum BH, et al. Planta Med. 2010. Open Source ↗

8. Adverse Effects

Key Takeaway

Short-term tolerability is generally good. Reported effects are predominantly activating: over-stimulation/restlessness, sleep disturbance (especially with late dosing), dizziness, dry mouth, and mild GI upset. A case of markedly elevated mood has been reported; long-term safety is not well characterized.

Effect	Frequency	Notes
Over-stimulation / restlessness / jitteriness	Common, mild	More likely at higher amounts
Difficulty sleeping	Common with late dosing	Take earlier in the day
Lightheadedness / dizziness	Uncommon	Usually transient
Dry mouth	Uncommon	—
Mild stomach upset	Uncommon	—
Markedly elevated, activated mood	Rare (case report)	Relevant with a specialist-managed mood condition or serotonergic mood medicines

Common, mild. Over-stimulation, restlessness or jitteriness (more likely at higher amounts), difficulty initiating sleep with afternoon/evening dosing, lightheadedness/dizziness, dry mouth, and mild gastrointestinal upset. National Center for Complementary and Integrative Health. Rhodiola. 2020. Open Source ↗

Notable. A published case describes an episode of markedly elevated, activated mood temporally associated with rhodiola use — relevant where a patient has a specialist-managed mood condition (Section 10). When rhodiola is combined with serotonergic mood medicines, case reports describe an over-stimulation picture (restlessness, tremor, autonomic features, in some reports an irregular heartbeat). Whig R, Leo RJ. Prim Care Companion CNS Disord. 2022. Open Source ↗ Maniscalco I, et al. Neuropsychiatr. 2015. Open Source ↗

Long-term. Long-duration safety data are limited; this informs the traditional practice of time-limited courses.

9. Drug Interactions

Key Takeaway

Two interaction routes dominate: pharmacodynamic additivity with serotonergic/MAO-active agents, and pharmacokinetic inhibition of CYP2C9, CYP3A4 and P-glycoprotein (raising substrate exposure). Additive effects with glucose-lowering and antihypertensive agents are also described. Rhodiola is an enzyme inhibitor, not a nutrient depleter.

9A. By Mechanism

Pharmacodynamic (serotonergic / MAO). In-vitro MAO inhibition and serotonergic activity underlie an additive risk with serotonergic mood medicines; case reports describe an over-stimulation picture on co-administration. Maniscalco I, et al. Neuropsychiatr. 2015. Open Source ↗ Pharmacokinetic (CYP / P-gp). Rhodiola inhibits CYP3A4 and P-glycoprotein in vitro and has shown human inhibition of CYP2C9 — raising the potential exposure of narrow-margin substrates (e.g., warfarin, phenytoin). Additive physiological. Possible additive effects with glucose-lowering and blood-pressure–lowering agents warrant monitoring. Hellum BH, et al. Planta Med. 2010. Open Source ↗

9B. Herb–Drug Interaction & Drug-Nutrient Depletion Table

Rhodiola is an enzyme inhibitor rather than a nutrient depleter — no clinically meaningful nutrient depletion is established. The table summarizes the herb→drug interactions that follow from that inhibition and from its pharmacodynamic activity.

Agent / class	Direction of effect when combined	Mechanism
Serotonergic mood medicines & MAO-active agents	↑ over-stimulation risk (additive)	pharmacodynamic — serotonergic / MAO activity
Warfarin (and other CYP2C9 substrates, e.g., phenytoin)	↑ substrate exposure / effect possible (watch INR)	CYP2C9 inhibition
CYP3A4 substrates (narrow margin)	↑ substrate exposure possible	CYP3A4 inhibition (in vitro)
P-glycoprotein substrates	↑ substrate exposure possible	P-gp inhibition (in vitro)
Glucose-lowering agents	additive — monitor blood sugar	possible additive physiological effect
Blood-pressure–lowering agents	additive — monitor blood pressure	possible additive physiological effect
Dietary nutrients	no established depletion	rhodiola is an enzyme inhibitor, not a depleter

10. Cautions and Considerations

Key Takeaway

Use caution with serotonergic/MAO-active medicines, anticoagulants, glucose-lowering and antihypertensive agents, autoimmune conditions or immunosuppressants, hepatic/renal impairment, and the peri-operative window. A specialist-managed mood condition warrants specialist input. Pregnancy/lactation and <18: not recommended (P-3 / T-U).

10A. When to Use Caution or Avoid

Serotonergic / MAO-active mood medicines — additive risk; do not combine without prescriber oversight.
Anticoagulants (warfarin) & narrow-margin CYP2C9/3A4 substrates — potential for raised exposure; coordinate and monitor (e.g., INR).
Glucose-lowering and antihypertensive agents — additive potential; monitor blood sugar and blood pressure.
Autoimmune conditions / immunosuppressant therapy — discuss before use.
Hepatic or renal impairment — altered handling; clinician guidance.
Specialist-managed mood condition with a history of elevated-mood episodes — over-stimulation reported; defer to the managing specialist.
Peri-operative window — given possible effects on bleeding, glucose, and blood pressure, discontinuation roughly two weeks before surgery is commonly advised.

10B. Pregnancy & Lactation

P-3 — Insufficient evidence Lactation transfer: T-U (unknown)

Not recommended in pregnancy or lactation. There are no reliable human reproductive-safety data; whole-extract reproductive-toxicity data are not publicly available, and the EMA monograph states use in pregnancy is not recommended. For lactation, no transfer studies exist (relative infant dose is not calculable) and the CNS-penetrant metabolite p-tyrosol plus serotonergic activity mean infant exposure is unknown. The grade reflects absent evidence, not demonstrated safety — the appropriate disposition is avoidance. EMA Committee on Herbal Medicinal Products (HMPC). EU herbal monograph: Rhodiolae roseae rhizoma et radix. 2024. Open Source ↗

Routing: direct pregnancy questions to the OB or midwife, lactation and infant-exposure questions to the IBCLC and pediatrician, and questions about interacting prescription medicines to the prescriber or pharmacist.

11. Combinations & Synergy

Key Takeaway

The best-characterized blend is ADAPT-232 (rhodiola + eleuthero + schisandra). Caffeine and other stimulants stack additively with rhodiola's activating quality (caution). Avoid stacking with serotonergic agents.

11A. Rational Combinations

ADAPT-232 / fixed adaptogen blend (rhodiola + Eleutherococcus senticosus + Schisandra chinensis) — the most-studied combination in the cognitive-performance literature.
Other adaptogens (e.g., ashwagandha) — commonly stacked in practice; combination-specific evidence is limited.

11B. Combinations to Approach with Caution (Negative Stacking)

Caffeine and other stimulants — additive activation; may worsen jitteriness and sleep disruption.
Serotonergic / MAO-active agents — additive pharmacodynamic risk (see Section 9).

Panossian A, Wikman G, Sarris J. Phytomedicine. 2010. Open Source ↗

12. Lab Monitoring

Key Takeaway

There is no clinical assay for rhodiola or its markers — it is not measured directly. Monitoring is interaction-driven: INR with warfarin, and the usual glucose/blood-pressure monitoring when relevant agents are co-used.

12A. Monitoring

No clinical reference interval exists for salidroside or rosavin; rhodiola itself is not a monitored analyte. Monitoring is therefore directed at interacting drugs rather than at rhodiola levels: check INR around initiation/discontinuation if warfarin is co-used, and apply standard blood-glucose and blood-pressure monitoring where the patient uses relevant agents. Hellum BH, et al. Planta Med. 2010. Open Source ↗

12B. Lab Interference

Test	Interferent	Effect / mitigation
INR (warfarin monitoring)	Rhodiola (CYP2C9 inhibition)	May raise warfarin exposure and shift INR; check INR around starting/stopping and coordinate with prescriber
Therapeutic levels of CYP2C9/3A4 substrates (e.g., phenytoin)	Rhodiola	May raise measured drug levels; interpret levels in light of recent rhodiola use
Blood-glucose readings	Rhodiola (additive with glucose-lowering agents)	May contribute to lower readings alongside those agents; monitor
Rhodiola / salidroside level	—	No clinical assay exists; rhodiola itself is not measured

13. Traditional Medicine

Key Takeaway

Rhodiola is a classical northern adaptogen — Siberian, Scandinavian, and Soviet-Russian traditions for stamina and resilience. The adaptogen concept itself was formalized by Soviet science in the late 1960s.

Traditional use centers on the cold north: Siberian and Russian folk practice for endurance through hard conditions, and Scandinavian use of roseroot. Mid-20th-century Soviet research brought it into the laboratory and produced the formal "adaptogen" concept — a substance proposed to raise non-specific resistance to stressors — described by Soviet scientists in 1969. Modern standardized extracts used in trials descend from this lineage. Panossian A, Wikman G, Sarris J. Phytomedicine. 2010. Open Source ↗

14. Quality Control

Key Takeaway

Rhodiola is a high-adulteration botanical: species substitution (notably R. crenulata), synthetic-salidroside spiking, and wide marker variability are documented, alongside heavy-metal findings in some US-market products. Species-specific identity testing, marker standardization, contaminant screening, and CITES-compliant sustainable sourcing are essential.

Adulteration & identity. Market analyses have documented substitution with cheaper congeners (e.g., R. crenulata), spiking with synthetic salidroside to meet a label specification, and a substantial fraction of products failing authentication as true R. rosea. The rosavins (species-specific) plus orthogonal methods (HPTLC, DNA, NMR) are used to authenticate identity. Porwollik S, Jafari M. PLoS One. 2026. Open Source ↗

Contaminants & variability. A 2026 analysis of US-market rhodiola products reported wide variation in marker content (a product labeled to a low rosavins spec measured several-fold lower) and traces of heavy metals in some products — reinforcing the need for third-party contaminant screening. Porwollik S, Jafari M. PLoS One. 2026. Open Source ↗

Sustainability. Wild R. rosea has been over-harvested; the species was listed on CITES Appendix II (effective 2023), which regulates international trade in the wild plant. Cultivated, traceable sourcing is the responsible default. EMA Committee on Herbal Medicinal Products (HMPC). Assessment report on Rhodiola rosea L., rhizoma et radix. 2024. Open Source ↗

✓ Last Reviewed: June 2026